RADIOPHARM THERANOSTICS LIMITED - Announcements

Market Cap $17.62M Add to my watchlist

Healthcare Biotechnology

Announcements

Filter Results

All Price Sensitive Only

RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	1.4MB	Share
RAD	Notification regarding unquoted securities - RAD		24/04/24	16.99KB	Share
RAD	Radiopharm Ventures institutional & VC presentation		22/04/24	2.42MB	Share
RAD	Notice Under Section 708A		15/04/24	123.71KB	Share
RAD	Application for quotation of securities - RAD		15/04/24	15.68KB	Share
RAD	Results of Extraordinary General Meeting		15/04/24	129.42KB	Share
RAD	Presentation to Extraordinary General Meeting		15/04/24	574.69KB	Share
RAD	Initial Director's Interest Notice PH		26/03/24	238.44KB	Share
RAD	Final Director's Interest Notice MB		26/03/24	264.37KB	Share
RAD	Board Changes		26/03/24	183.12KB	Share
RAD	RAD to present at NWR Virtual Healthcare Conference		19/03/24	204.51KB	Share
RAD	RAD 301 and 302 data shows value of targeting avb6-integrin		15/03/24	381.24KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		15/03/24	704.35KB	Share
RAD	Notice Under Section 708A		12/03/24	124.06KB	Share
RAD	Application for quotation of securities - RAD		12/03/24	15.85KB	Share
RAD	Multiple RAD301 data releases to be presented at EMIM		06/03/24	254.09KB	Share
RAD	Notice Under Section 708A		04/03/24	123.77KB	Share
RAD	Application for quotation of securities - RAD		04/03/24	16.03KB	Share
RAD	B Riley Securities Radiopharma Conference Presentation		04/03/24	1.16MB	Share
RAD	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	1.55MB	Share
RAD	Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301	PRICE SENSITIVE	29/02/24	288.52KB	Share
RAD	Pilot Study Validates RAD Terbium-161 Radiotherapeutics	PRICE SENSITIVE	28/02/24	265.19KB	Share
RAD	Participation in B. Riley Securities Radiopharma Conference		23/02/24	204KB	Share
RAD	Radiopharm receives $1.9 M advance on FY24 R&D tax incentive	PRICE SENSITIVE	21/02/24	147.07KB	Share
RAD	Notice Under Section 708A		14/02/24	123.9KB	Share
RAD	Application for quotation of securities - RAD		14/02/24	15.89KB	Share
RAD	Application for quotation of securities - RAD		09/02/24	15.96KB	Share
RAD	Update - Proposed issue of securities - RAD		06/02/24	15.75KB	Share
RAD	RAD Share Facility Agreement of up to A$12.5m addendum		06/02/24	312.65KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	17.07KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.34KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.47KB	Share
RAD	RAD secures Share Facility Agreement of up to A$12.5m	PRICE SENSITIVE	06/02/24	308.86KB	Share
RAD	RAD 502 can halt tumour progression and prolong survival	PRICE SENSITIVE	05/02/24	308.3KB	Share
RAD	Application for quotation of securities - RAD		31/01/24	25.09KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	325.51KB	Share
RAD	Investor Presentation		24/01/24	1.54MB	Share
RAD	Placement of Entitlement Offer Shortfall	PRICE SENSITIVE	24/01/24	214.49KB	Share
RAD	Notice Under Section 708A		05/01/24	123.87KB	Share
RAD	Application for quotation of securities - RAD		05/01/24	25.53KB	Share
RAD	2nd Australian site for Nanomab-PDL-1 Phase 1 trial	PRICE SENSITIVE	27/12/23	303.62KB	Share
RAD	Notification regarding unquoted securities - RAD		22/12/23	23.81KB	Share
RAD	Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan	PRICE SENSITIVE	22/12/23	268.51KB	Share
RAD	Change of Director's Interest Notice x5		15/12/23	339.11KB	Share
RAD	Notice Under Section 708A		15/12/23	123.77KB	Share
RAD	Application for quotation of securities - RAD		15/12/23	25.49KB	Share
RAD	Application for quotation of securities - RAD		08/12/23	25.05KB	Share
RAD	Completion of Entitlement Offer	PRICE SENSITIVE	08/12/23	162.94KB	Share
RAD	Change of Director's Interest Notice - PH IT RC		07/12/23	401.54KB	Share
RAD	Notification regarding unquoted securities - RAD		01/12/23	27.06KB	Share
RAD	Application for quotation of securities - RAD		24/11/23	25.21KB	Share
RAD	Amended Constitution		22/11/23	594.02KB	Share
RAD	Radiopharm receives $4.85M R&D tax incentive	PRICE SENSITIVE	21/11/23	148.63KB	Share
RAD	Update - Proposed issue of securities - RAD		21/11/23	28.34KB	Share
RAD	Entitlement Offer closing date extended to 1 December 2023		21/11/23	136.94KB	Share
RAD	Notification of Release of Shares from Escrow		16/11/23	145.03KB	Share
RAD	Results of Annual General Meeting		16/11/23	127.94KB	Share
RAD	Presentation to Annual General Meeting		16/11/23	737.12KB	Share
RAD	Bell Potter Healthcare Conference Presentation		15/11/23	1.62MB	Share
RAD	Entitlement Offer Documents	PRICE SENSITIVE	08/11/23	5.39MB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	1.47MB	Share
RAD	Entitlement Offer cleansing notice under section 708AA		31/10/23	211.73KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	24.47KB	Share
RAD	Investor webinar		31/10/23	131.08KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	28.68KB	Share
RAD	Investor Presentation - Entitlement Offer		31/10/23	1.56MB	Share
RAD	Entitlement Offer to raise approximately $10 million	PRICE SENSITIVE	31/10/23	228.3KB	Share
RAD	Notice of Annual General Meeting/Proxy Form		18/10/23	500.73KB	Share
RAD	FDA green light for diagnostic Phase 1 pancreatic trial	PRICE SENSITIVE	17/10/23	178.96KB	Share
RAD	RAD receives approval for Phase 1 therapeutic study of NSCLC	PRICE SENSITIVE	09/10/23	134.02KB	Share
RAD	ESG Report		28/09/23	1.07MB	Share
RAD	Appendix 4G		28/09/23	332.93KB	Share
RAD	Corporate Governance Statement		28/09/23	888.09KB	Share
RAD	Annual Report to shareholders		28/09/23	1.82MB	Share
RAD	Appendix 4E and FY23 Financial Report	PRICE SENSITIVE	31/08/23	1.79MB	Share
RAD	TerThera Terbium-161 isotope supply agreement expanded	PRICE SENSITIVE	24/08/23	220.37KB	Share
RAD	Results of Meeting		18/08/23	121.18KB	Share
RAD	EGM Presentation		18/08/23	364.99KB	Share
RAD	Change of Director's Interest Notice IT		08/08/23	175.8KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	1.33MB	Share
RAD	Dr Sherin Al-Safadi appointed VP Medical & Corporate Affairs		24/07/23	132.41KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		20/07/23	383.69KB	Share
RAD	Notification of cessation of securities - RAD		30/06/23	21.85KB	Share
RAD	Notification regarding unquoted securities - RAD		30/06/23	25.26KB	Share
RAD	Pivalate educational webinar 14 June 2023		13/06/23	134.24KB	Share
RAD	FDA Pre-IND meeting supports an IND application for RAD 101	PRICE SENSITIVE	29/05/23	132.08KB	Share
RAD	RAD 301 receives FDA Orphan Drug Designation	PRICE SENSITIVE	09/05/23	227.82KB	Share
RAD	Application for quotation of securities - RAD		28/04/23	26.55KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	1.46MB	Share
RAD	Agreement with TerThera to supply Terbium-161 isotope	PRICE SENSITIVE	17/04/23	234.32KB	Share
RAD	Radiopharm Receives $1.56M R&D Tax Incentive		28/03/23	150.14KB	Share
RAD	Radiopharm to participate in Jefferies Radiopharma Summit		28/03/23	152KB	Share
RAD	RAD and GenesisCare to Develop Novel Radiopharmaceuticals		27/03/23	197.97KB	Share
RAD	RAD to present at virtual healthcare conference		17/03/23	130.43KB	Share
RAD	Notice Under Section 708A		06/03/23	124.03KB	Share
RAD	Application for quotation of securities - RAD		06/03/23	25.17KB	Share
RAD	Dr Ken Herrmann appointed to RAD Scientific Advisory Board		03/03/23	110.69KB	Share
RAD	Radiopharm to acquire Pharma15 Corporation	PRICE SENSITIVE	03/03/23	152.64KB	Share
RAD	Proposed issue of securities - RAD		03/03/23	24.82KB	Share
RAD	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/23	1.56MB	Share

RAD Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	1.4MB	Share
RAD Notification regarding unquoted securities - RAD
24/04/24		16.99KB	Share
RAD Radiopharm Ventures institutional & VC presentation
22/04/24		2.42MB	Share
RAD Notice Under Section 708A
15/04/24		123.71KB	Share
RAD Application for quotation of securities - RAD
15/04/24		15.68KB	Share
RAD Results of Extraordinary General Meeting
15/04/24		129.42KB	Share
RAD Presentation to Extraordinary General Meeting
15/04/24		574.69KB	Share
RAD Initial Director's Interest Notice PH
26/03/24		238.44KB	Share
RAD Final Director's Interest Notice MB
26/03/24		264.37KB	Share
RAD Board Changes
26/03/24		183.12KB	Share
RAD RAD to present at NWR Virtual Healthcare Conference
19/03/24		204.51KB	Share
RAD RAD 301 and 302 data shows value of targeting avb6-integrin
15/03/24		381.24KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
15/03/24		704.35KB	Share
RAD Notice Under Section 708A
12/03/24		124.06KB	Share
RAD Application for quotation of securities - RAD
12/03/24		15.85KB	Share
RAD Multiple RAD301 data releases to be presented at EMIM
06/03/24		254.09KB	Share
RAD Notice Under Section 708A
04/03/24		123.77KB	Share
RAD Application for quotation of securities - RAD
04/03/24		16.03KB	Share
RAD B Riley Securities Radiopharma Conference Presentation
04/03/24		1.16MB	Share
RAD Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	1.55MB	Share
RAD Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301
29/02/24	PRICE SENSITIVE	288.52KB	Share
RAD Pilot Study Validates RAD Terbium-161 Radiotherapeutics
28/02/24	PRICE SENSITIVE	265.19KB	Share
RAD Participation in B. Riley Securities Radiopharma Conference
23/02/24		204KB	Share
RAD Radiopharm receives $1.9 M advance on FY24 R&D tax incentive
21/02/24	PRICE SENSITIVE	147.07KB	Share
RAD Notice Under Section 708A
14/02/24		123.9KB	Share
RAD Application for quotation of securities - RAD
14/02/24		15.89KB	Share
RAD Application for quotation of securities - RAD
09/02/24		15.96KB	Share
RAD Update - Proposed issue of securities - RAD
06/02/24		15.75KB	Share
RAD RAD Share Facility Agreement of up to A$12.5m addendum
06/02/24		312.65KB	Share
RAD Proposed issue of securities - RAD
06/02/24		17.07KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.34KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.47KB	Share
RAD RAD secures Share Facility Agreement of up to A$12.5m
06/02/24	PRICE SENSITIVE	308.86KB	Share
RAD RAD 502 can halt tumour progression and prolong survival
05/02/24	PRICE SENSITIVE	308.3KB	Share
RAD Application for quotation of securities - RAD
31/01/24		25.09KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	325.51KB	Share
RAD Investor Presentation
24/01/24		1.54MB	Share
RAD Placement of Entitlement Offer Shortfall
24/01/24	PRICE SENSITIVE	214.49KB	Share
RAD Notice Under Section 708A
05/01/24		123.87KB	Share
RAD Application for quotation of securities - RAD
05/01/24		25.53KB	Share
RAD 2nd Australian site for Nanomab-PDL-1 Phase 1 trial
27/12/23	PRICE SENSITIVE	303.62KB	Share
RAD Notification regarding unquoted securities - RAD
22/12/23		23.81KB	Share
RAD Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan
22/12/23	PRICE SENSITIVE	268.51KB	Share
RAD Change of Director's Interest Notice x5
15/12/23		339.11KB	Share
RAD Notice Under Section 708A
15/12/23		123.77KB	Share
RAD Application for quotation of securities - RAD
15/12/23		25.49KB	Share
RAD Application for quotation of securities - RAD
08/12/23		25.05KB	Share
RAD Completion of Entitlement Offer
08/12/23	PRICE SENSITIVE	162.94KB	Share
RAD Change of Director's Interest Notice - PH IT RC
07/12/23		401.54KB	Share
RAD Notification regarding unquoted securities - RAD
01/12/23		27.06KB	Share
RAD Application for quotation of securities - RAD
24/11/23		25.21KB	Share
RAD Amended Constitution
22/11/23		594.02KB	Share
RAD Radiopharm receives $4.85M R&D tax incentive
21/11/23	PRICE SENSITIVE	148.63KB	Share
RAD Update - Proposed issue of securities - RAD
21/11/23		28.34KB	Share
RAD Entitlement Offer closing date extended to 1 December 2023
21/11/23		136.94KB	Share
RAD Notification of Release of Shares from Escrow
16/11/23		145.03KB	Share
RAD Results of Annual General Meeting
16/11/23		127.94KB	Share
RAD Presentation to Annual General Meeting
16/11/23		737.12KB	Share
RAD Bell Potter Healthcare Conference Presentation
15/11/23		1.62MB	Share
RAD Entitlement Offer Documents
08/11/23	PRICE SENSITIVE	5.39MB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	1.47MB	Share
RAD Entitlement Offer cleansing notice under section 708AA
31/10/23		211.73KB	Share
RAD Proposed issue of securities - RAD
31/10/23		24.47KB	Share
RAD Investor webinar
31/10/23		131.08KB	Share
RAD Proposed issue of securities - RAD
31/10/23		28.68KB	Share
RAD Investor Presentation - Entitlement Offer
31/10/23		1.56MB	Share
RAD Entitlement Offer to raise approximately $10 million
31/10/23	PRICE SENSITIVE	228.3KB	Share
RAD Notice of Annual General Meeting/Proxy Form
18/10/23		500.73KB	Share
RAD FDA green light for diagnostic Phase 1 pancreatic trial
17/10/23	PRICE SENSITIVE	178.96KB	Share
RAD RAD receives approval for Phase 1 therapeutic study of NSCLC
09/10/23	PRICE SENSITIVE	134.02KB	Share
RAD ESG Report
28/09/23		1.07MB	Share
RAD Appendix 4G
28/09/23		332.93KB	Share
RAD Corporate Governance Statement
28/09/23		888.09KB	Share
RAD Annual Report to shareholders
28/09/23		1.82MB	Share
RAD Appendix 4E and FY23 Financial Report
31/08/23	PRICE SENSITIVE	1.79MB	Share
RAD TerThera Terbium-161 isotope supply agreement expanded
24/08/23	PRICE SENSITIVE	220.37KB	Share
RAD Results of Meeting
18/08/23		121.18KB	Share
RAD EGM Presentation
18/08/23		364.99KB	Share
RAD Change of Director's Interest Notice IT
08/08/23		175.8KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	1.33MB	Share
RAD Dr Sherin Al-Safadi appointed VP Medical & Corporate Affairs
24/07/23		132.41KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
20/07/23		383.69KB	Share
RAD Notification of cessation of securities - RAD
30/06/23		21.85KB	Share
RAD Notification regarding unquoted securities - RAD
30/06/23		25.26KB	Share
RAD Pivalate educational webinar 14 June 2023
13/06/23		134.24KB	Share
RAD FDA Pre-IND meeting supports an IND application for RAD 101
29/05/23	PRICE SENSITIVE	132.08KB	Share
RAD RAD 301 receives FDA Orphan Drug Designation
09/05/23	PRICE SENSITIVE	227.82KB	Share
RAD Application for quotation of securities - RAD
28/04/23		26.55KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	1.46MB	Share
RAD Agreement with TerThera to supply Terbium-161 isotope
17/04/23	PRICE SENSITIVE	234.32KB	Share
RAD Radiopharm Receives $1.56M R&D Tax Incentive
28/03/23		150.14KB	Share
RAD Radiopharm to participate in Jefferies Radiopharma Summit
28/03/23		152KB	Share
RAD RAD and GenesisCare to Develop Novel Radiopharmaceuticals
27/03/23		197.97KB	Share
RAD RAD to present at virtual healthcare conference
17/03/23		130.43KB	Share
RAD Notice Under Section 708A
06/03/23		124.03KB	Share
RAD Application for quotation of securities - RAD
06/03/23		25.17KB	Share
RAD Dr Ken Herrmann appointed to RAD Scientific Advisory Board
03/03/23		110.69KB	Share
RAD Radiopharm to acquire Pharma15 Corporation
03/03/23	PRICE SENSITIVE	152.64KB	Share
RAD Proposed issue of securities - RAD
03/03/23		24.82KB	Share
RAD Appendix 4D and Half Year Report
28/02/23	PRICE SENSITIVE	1.56MB	Share

REFRESH

1 2

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $17.62M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.9¢	$6.473K	164.9K

Buyers (Bids)

No.	Vol.	Price($)
2	149276	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	227494	3

View Market Depth

No.	Vol.	Price($)
2	149276	0.039
4	38501	0.038
1	30000	0.037
1	3000	0.036
1	15000	0.035

Price($)	Vol.	No.
0.040	227494	3
0.041	51572	3
0.042	29722	1
0.045	78510	1
0.048	100000	1

Last trade - 13.26pm 02/05/2024 (20 minute delay)


Last 3.9¢		Change -0.001 ( 11.4 %)
Open	High	Low	Volume
4.0¢	4.0¢	3.9¢	40036
Last updated 13.26pm 02/05/2024 ?

RAD (ASX) Chart

RADIOPHARM THERANOSTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories